A detailed history of Keystone Financial Services transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Keystone Financial Services holds 1,069 shares of CRL stock, worth $200,865. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,069
Previous 1,069 -0.0%
Holding current value
$200,865
Previous $220,000 4.55%
% of portfolio
0.08%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$206.39 - $268.73 $206 - $268
-1 Reduced 0.09%
1,069 $220,000
Q1 2024

Jun 13, 2024

BUY
$203.52 - $273.43 $42,128 - $56,600
207 Added 23.99%
1,070 $289,000
Q4 2023

Jan 29, 2024

BUY
$164.52 - $238.84 $141,980 - $206,118
863 New
863 $204,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Keystone Financial Services Portfolio

Follow Keystone Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Services with notifications on news.